Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Peptic Ulcer

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 68 articles:
HTML format



Single Articles


    July 2022
  1. ZHOU Y
    Proton Pump Inhibitors and Risk of Mortality: Longer and More Dangerous?
    Am J Gastroenterol. 2022;117:1171-1172.
    PubMed    


    June 2022
  2. WANG R, Bai D, Xiang W, Chen XZ, et al
    Tibetan Ethnicity, Birthplace, Helicobacter pylori Infection, and Gastric Cancer Risk.
    Am J Gastroenterol. 2022;117:1010.
    PubMed    


    May 2022
  3. HO JJC, Navarro M, Sawyer K, Elfanagely Y, et al
    Helicobacter pylori Antibiotic Resistance in the United States Between 2011-2021: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2022 May 5. pii: 00000434-990000000-00369.
    PubMed     Abstract available


  4. PARK JY, Yoo J, Jeon J, Kim J, et al
    Proton pump inhibitors and risk of cardiovascular disease: a self-controlled case series study.
    Am J Gastroenterol. 2022 May 4. pii: 00000434-990000000-00361.
    PubMed     Abstract available


    April 2022
  5. DEWITT J, Kessler W, Wo J, Stainko S, et al
    SYMPTOM ASSOCIATION FOR GASTROESOPHAGEAL REFLUX DISEASE BY PH MONITORING AFTER PERORAL ENDOSCOPIC MYOTOMY: GERD and symptoms after POEM.
    Am J Gastroenterol. 2022 Apr 25. pii: 00000434-990000000-00351.
    PubMed     Abstract available


    March 2022
  6. VENKAT PG, Longstreth GF
    Gastroesophageal Reflux Disease and the Zollinger-Ellison Syndrome.
    Am J Gastroenterol. 2022 Mar 28. pii: 00000434-990000000-00307.
    PubMed    


  7. LAINE L, Sharma P, Mulford DJ, Hunt B, et al
    PHARMACODYNAMICS AND PHARMACOKINETICS OF THE POTASSIUM-COMPETITIVE ACID BLOCKER VONOPRAZAN AND THE PROTON PUMP INHIBITOR LANSOPRAZOLE IN U.S. SUBJECTS.
    Am J Gastroenterol. 2022 Mar 16. pii: 00000434-990000000-00284.
    PubMed     Abstract available


    January 2022
  8. GRAHAM DY, Moss SF
    Antimicrobial susceptibility testing for Helicobacter pylori is now widely available: When, How, Why.
    Am J Gastroenterol. 2022 Jan 25. pii: 00000434-990000000-00227.
    PubMed    


    December 2021
  9. SCHUITENMAKER JM, van Dijk M, Oude Nijhuis RAB, Smout AJPM, et al
    Associations Between Sleep Position and Nocturnal Gastroesophageal Reflux: A Study Using Concurrent Monitoring of Sleep Position and Esophageal pH and Impedance.
    Am J Gastroenterol. 2021 Dec 20. pii: 00000434-990000000-00170.
    PubMed     Abstract available


  10. VITOR MS, Tiago LC, Marta F, Tiago CG, et al
    P020 Proton Pump Inhibitor Therapy: Providing "Acid" Outcomes in Patients With Inflammatory Bowel Disease Under Infliximab Treatment.
    Am J Gastroenterol. 2021;116.
    PubMed    


  11. MACEDO SILVA V, Lima Capela T, Freitas M, Curdia Goncalves T, et al
    P020 Proton Pump Inhibitor Therapy: Providing "Acid" Outcomes in Patients With Inflammatory Bowel Disease Under Infliximab Treatment.
    Am J Gastroenterol. 2021;116.
    PubMed     Abstract available


    November 2021
  12. KATZ PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, et al
    ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.
    Am J Gastroenterol. 2021 Nov 22. pii: 00000434-990000000-00154.
    PubMed     Abstract available


    September 2021
  13. BHATTACHARYA S, Blau JE, Cochran C, Auh S, et al
    Validity of Secretin Stimulation Testing on Proton Pump Inhibitor Therapy for Diagnosis of Zollinger-Ellison Syndrome.
    Am J Gastroenterol. 2021 Sep 13. pii: 00000434-990000000-00098.
    PubMed     Abstract available


    August 2021
  14. CHENG YY, Tsai MC, Wei JC
    Response to "Increased ACE2 Levels and Mortality Risk of Patients With COVID-19 on Proton Pump Inhibitor Therapy".
    Am J Gastroenterol. 2021 Aug 27. pii: 00000434-990000000-00086.
    PubMed    


  15. LV XH, Wang ZJ, Yang JL
    Proton Pump Inhibitors and COVID-19: Confusing Status Quo.
    Am J Gastroenterol. 2021 Aug 16. pii: 00000434-990000000-00070.
    PubMed    


    July 2021
  16. HE Q, Xia B, Meng W, Fan D, et al
    No Associations Between Regular Use of Proton Pump Inhibitors and Risk of All-Cause and Cause-Specific Mortality: A Population-Based Cohort of 0.44 Million Participants.
    Am J Gastroenterol. 2021 Jul 27. pii: 00000434-990000000-00057.
    PubMed     Abstract available


  17. SINGH AD, Zhang X, Anwer F, Bhatt A, et al
    Isolated Gastric Amyloid Light Chain Amyloidosis Causing Upper Gastrointestinal Bleeding.
    Am J Gastroenterol. 2021 Jul 23. pii: 00000434-990000000-00056.
    PubMed    


  18. RIBOLSI M, Luca Guarino MP, Balestrieri P, Altomare A, et al
    The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough.
    Am J Gastroenterol. 2021 Jul 21. pii: 00000434-990000000-00054.
    PubMed     Abstract available


  19. LABENZ C, Labenz J
    Proton Pump Inhibitors in Patients With Liver Cirrhosis: Evidence to Improve Their Battered Reputation.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00048.
    PubMed    


  20. ZHANG B, Hu Y, Shi X, Li W, et al
    Integrative Effects and Vagal Mechanisms of Transcutaneous Electrical Acustimulation on Gastroesophageal Motility in Patients With Gastroesophageal Reflux Disease.
    Am J Gastroenterol. 2021;116:1495-1505.
    PubMed     Abstract available


    June 2021
  21. SHIN GY, Park JM, Hong J, Cho YK, et al
    Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
    Am J Gastroenterol. 2021;116:1211-1219.
    PubMed     Abstract available


    May 2021
  22. LIU JJ, Sloan ME, Owings AH, Figgins E, et al
    Increased ACE2 Levels and Mortality Risk of Patients With COVID-19 on Proton Pump Inhibitor Therapy.
    Am J Gastroenterol. 2021 May 27. pii: 00000434-900000000-98767.
    PubMed     Abstract available


  23. WATANABE K, Shimodaira Y, Takahashi S, Fukuda S, et al
    Potent Acid Suppression With Vonoprazan vs Proton Pump Inhibitors Does Not Have Higher Association With Clostridioides difficile Infection.
    Am J Gastroenterol. 2021 May 13. pii: 00000434-900000000-98781.
    PubMed     Abstract available


  24. BOTTERI E, Gallus S, Lugo A
    Response to Hoffmeister et al.
    Am J Gastroenterol. 2021;116:1093-1094.
    PubMed    


  25. TSAY CJ, Protiva P
    Chronic Mesenteric Ischemia With Peristaltic Blanching.
    Am J Gastroenterol. 2021;116:870.
    PubMed    


    April 2021
  26. NYSSEN OP, Perez-Aisa A, Tepes B, Castro-Fernandez M, et al
    Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg).
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98822.
    PubMed     Abstract available


    February 2021
  27. BISSELING TM, van Laarhoven A, Huijbers A, Brink M, et al
    Coronavirus Disease-19 Presenting as Esophageal Ulceration.
    Am J Gastroenterol. 2021;116:421-424.
    PubMed    


    January 2021
  28. SUGIYAMA T
    Long-Term Safety of Proton Pump Inhibitors: Bone Fracture Risk as an Example.
    Am J Gastroenterol. 2021 Jan 22. pii: 00000434-900000000-98932.
    PubMed    


    December 2020
  29. LISA Y, Robert C
    P051 Proton Pump Inhibitors are Associated with Less Severe Periodontal Disease: Considerations for IBD Patients.
    Am J Gastroenterol. 2020;115.
    PubMed    


    November 2020
  30. ALMARIO CV, Chey WD, Spiegel BMR
    Response to Hajifathalian and Katz Regarding Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors.
    Am J Gastroenterol. 2020;115:1922-1923.
    PubMed    


  31. BOUSHEY H, Gonda I
    Comment on Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors.
    Am J Gastroenterol. 2020;115:1921.
    PubMed    


  32. TARLOW B, Gubatan J, Khan MA, Cholankeril G, et al
    Are Proton Pump Inhibitors Contributing to SARS-COV-2 Infection?
    Am J Gastroenterol. 2020;115:1920-1921.
    PubMed    


  33. HADI YB, Naqvi SF, Kupec JT
    Risk of COVID-19 in Patients Taking Proton Pump Inhibitors.
    Am J Gastroenterol. 2020;115:1919-1920.
    PubMed    


  34. HAJIFATHALIAN K, Katz PO
    Regarding "Increased Risk of COVID-19 in Patients Taking Proton Pump Inhibitors".
    Am J Gastroenterol. 2020;115:1918-1919.
    PubMed    


  35. ABY ES, Rodin H, Debes JD
    Proton Pump Inhibitors and Mortality in Individuals With COVID-19.
    Am J Gastroenterol. 2020;115:1918.
    PubMed    


  36. KOTHARI TH, Enslin S, Cheong J, Kaul V, et al
    Treatment of Bouveret Syndrome Using an Ultrathin Gastroscope: Making the Best out of a Tight Situation!
    Am J Gastroenterol. 2020;115:1748.
    PubMed    


    October 2020
  37. GUO H, Lam AY, Shaheen AA, Forbes N, et al
    Urban-Rural Disparities and Temporal Trends in Peptic Ulcer Disease Epidemiology, Treatment, and Outcomes in the United States.
    Am J Gastroenterol. 2020 Oct 22. doi: 10.14309/ajg.0000000000000997.
    PubMed     Abstract available


  38. BOUSHEY H, Gonda I
    Comment on Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors.
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001014.
    PubMed    


  39. HAJIFATHALIAN K, Katz PO
    Regarding "Increased Risk of COVID-19" in Patients Taking Proton Pump Inhibitors.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000920.
    PubMed    


  40. HADI YB, Naqvi SF, Kupec JT
    Risk of COVID-19 in Patients Taking Proton Pump Inhibitors.
    Am J Gastroenterol. 2020 Oct 1. doi: 10.14309/ajg.0000000000000949.
    PubMed    


  41. MARTIN TA, Wan DW, Hajifathalian K, Tewani S, et al
    Gastrointestinal Bleeding in Patients With Coronavirus Disease 2019: A Matched Case-Control Study.
    Am J Gastroenterol. 2020;115:1609-1616.
    PubMed     Abstract available


    September 2020
  42. ABY ES, Rodin H, Debes JD
    Proton Pump Inhibitors and Mortality in Individuals With COVID-19.
    Am J Gastroenterol. 2020 Sep 30. doi: 10.14309/ajg.0000000000000992.
    PubMed    


  43. HALLAND M, Bharucha AE, Crowell MD, Ravi K, et al
    Effects of Diaphragmatic Breathing on the Pathophysiology and Treatment of Upright Gastroesophageal Reflux: A Randomized Controlled Trial.
    Am J Gastroenterol. 2020 Sep 30. doi: 10.14309/ajg.0000000000000913.
    PubMed     Abstract available


  44. TARLOW B, Gubatan J, Khan MA, Cholankeril G, et al
    Are Proton Pump Inhibitors Contributing to SARS-COV-2 Infection?
    Am J Gastroenterol. 2020 Sep 11. doi: 10.14309/ajg.0000000000000933.
    PubMed    


    August 2020
  45. ALMARIO CV, Chey WD, Spiegel BMR
    Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors.
    Am J Gastroenterol. 2020 Aug 25. doi: 10.14309/ajg.0000000000000798.
    PubMed     Abstract available


  46. SKOLE KS, Mahpour NY
    There Are Several Reasons to Not Treat H. pylori....
    Am J Gastroenterol. 2020;115:1301.
    PubMed    


    July 2020
  47. KAMAL AN, Clarke JO, Oors JM, Smout AJ, et al
    The Role of Symptom Association Analysis in Gastroesophageal Reflux Testing.
    Am J Gastroenterol. 2020 Jul 29. doi: 10.14309/ajg.0000000000000754.
    PubMed     Abstract available


  48. LI X, Huang S, Lu J, Lai R, et al
    Upper Gastrointestinal Bleeding Caused by SARS-CoV-2 Infection.
    Am J Gastroenterol. 2020 Jul 20. doi: 10.14309/ajg.0000000000000757.
    PubMed    


  49. SONNENBERG A, Turner KO, Genta RM
    Correction: Low Prevalence of Helicobacter pylori-Positive Peptic Ulcers in Private Outpatient Endoscopy Centers in the United States.
    Am J Gastroenterol. 2020;115:1145.
    PubMed    


  50. MELAZZINI F, Lenti MV, Mauro A, De Grazia F, et al
    Peptic Ulcer Disease as a Common Cause of Bleeding in Patients with Coronavirus Disease 2019.
    Am J Gastroenterol. 2020;115:1139-1140.
    PubMed    


    May 2020
  51. GAJENDRAN M, Perisetti A, Goyal H
    Timing of Feeding After Endoscopic Intervention in Peptic Ulcer Disease.
    Am J Gastroenterol. 2020 May 27. doi: 10.14309/ajg.0000000000000698.
    PubMed    


  52. GEERAERTS A, Van Houtte B, Clevers E, Geysen H, et al
    Gastroesophageal Reflux Disease-Functional Dyspepsia Overlap: Do Birds of a Feather Flock Together?
    Am J Gastroenterol. 2020 May 25. doi: 10.14309/ajg.0000000000000619.
    PubMed     Abstract available


  53. MELAZZINI F, Lenti MV, Mauro A, De Grazia F, et al
    Peptic Ulcer Disease as a Common Cause of Bleeding in Patients with Coronavirus Disease 2019.
    Am J Gastroenterol. 2020 May 22. doi: 10.14309/ajg.0000000000000710.
    PubMed    


  54. KUMAR S, Metz DC, Kaplan DE, Goldberg DS, et al
    Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection.
    Am J Gastroenterol. 2020;115:716-722.
    PubMed     Abstract available


  55. SHEPHERD K, Ockelford J, Ganasan V, Holloway R, et al
    Temporal Relationship Between Night-Time Gastroesophageal Reflux Events and Arousals From Sleep.
    Am J Gastroenterol. 2020;115:697-705.
    PubMed     Abstract available


  56. LONGSTRETH GF
    Internists' Misconceptions About PPIs: Increasing Knowledge and Implementing Guidelines.
    Am J Gastroenterol. 2020;115:681-682.
    PubMed     Abstract available


  57. BAZERBACHI F, Chandrasekhara V
    Ulcere Perfore-Bouche.
    Am J Gastroenterol. 2020;115:649.
    PubMed    


    March 2020
  58. LEE JK, Merchant SA, Schneider JL, Jensen CD, et al
    Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population.
    Am J Gastroenterol. 2020 Mar 20. doi: 10.14309/ajg.0000000000000591.
    PubMed     Abstract available


  59. GONG EJ, Lee SJ, Jun BG, Seo HI, et al
    Optimal Timing of Feeding After Endoscopic Hemostasis in Patients With Peptic Ulcer Bleeding: A Randomized, Noninferiority Trial (CRIS KCT0001019).
    Am J Gastroenterol. 2020 Mar 20. doi: 10.14309/ajg.0000000000000584.
    PubMed     Abstract available


  60. SONNENBERG A, Turner KO, Genta RM
    Correction: Low Prevalence of Helicobacter pylori-Positive Peptic Ulcers in Private Outpatient Endoscopy Centers in the United States.
    Am J Gastroenterol. 2020 Mar 5. doi: 10.14309/ajg.0000000000000592.
    PubMed    


  61. LAI SW, Liao KF
    Association Between Proton Pump Inhibitors Use and Dementia Risk.
    Am J Gastroenterol. 2020 Mar 4. doi: 10.14309/ajg.0000000000000576.
    PubMed    


    February 2020
  62. KURLANDER JE, Rubenstein JH, Richardson CR, Krein SL, et al
    Physicians' Perceptions of Proton Pump Inhibitor Risks and Recommendations to Discontinue: A National Survey.
    Am J Gastroenterol. 2020 Feb 24. doi: 10.14309/ajg.0000000000000558.
    PubMed     Abstract available


  63. BAGGOTT BB, Vogt D, Harris KB, Vargo JJ, et al
    Pancreatic Rest Tissue: An Unusual Cause of Nonhealing Gastric Ulcer.
    Am J Gastroenterol. 2020 Feb 5. doi: 10.14309/ajg.0000000000000524.
    PubMed    


    January 2020
  64. SONNENBERG A, Turner KO, Genta RM
    Low Prevalence of Helicobacter pylori-Positive Peptic Ulcers in Private Outpatient Endoscopy Centers in the United States.
    Am J Gastroenterol. 2020 Jan 15. doi: 10.14309/ajg.0000000000000517.
    PubMed     Abstract available


  65. KHAN MA, Yuan Y, Iqbal U, Kamal S, et al
    No Association Linking Short-Term Proton Pump Inhibitor Use to Dementia: Systematic Review and Meta-analysis of Observational Studies.
    Am J Gastroenterol. 2020 Jan 2. doi: 10.14309/ajg.0000000000000500.
    PubMed     Abstract available


    October 2019
  66. CHEY WD
    Helicobacter pylori: When We Should Treat....
    Am J Gastroenterol. 2019 Oct 25. doi: 10.14309/ajg.0000000000000425.
    PubMed    


    May 2019
  67. WIENS EJ, Mylnikov A
    Hypoxic Respiratory Failure Complicating Esophagogastroduodenoscopy.
    Am J Gastroenterol. 2019;114:706.
    PubMed    


    March 2019
  68. HUNGIN APS, Molloy-Bland M, Scarpignato C
    Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD.
    Am J Gastroenterol. 2019;114:414-421.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: